WallStreetZenWallStreetZen

NASDAQ: COO
Cooper Companies Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for COO

Based on 8 analysts offering 12 month price targets for Cooper Companies Inc

Min Forecast
$76.00+1.04%
Avg Forecast
$96.25+27.96%
Max Forecast
$110.00+46.24%

Should I buy or sell COO stock?

Based on 8 analysts offering ratings for Cooper Companies Inc.

Strong Buy
Strong Buy
4 analysts 50%
Buy
3 analysts 37.5%
Hold
1 analysts 12.5%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although COO's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates COO as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their COO stock forecasts and price targets.

COO stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-07-16
lockedlocked$00.00+00.00%2025-06-17
lockedlocked$00.00+00.00%2025-05-30
lockedlocked$00.00+00.00%2025-05-30
lockedlocked$00.00+00.00%2025-05-30
JP Morgan
Top 26%
75
HoldDowngrades$76.00+1.04%2025-05-30
Stifel Nicolaus
Bottom 9%
9
Strong BuyMaintains$105.00+39.59%2025-03-07
Citigroup
Top 6%
95
Strong BuyMaintains$110.00+46.24%2025-03-07

1 of 1

Forecast return on equity

Is COO forecast to generate an efficient return?

Company
11.91%
Industry
17.6%
Market
-19.28%
COO's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is COO forecast to generate an efficient return on assets?

Company
7.95%
Industry
12.55%
COO is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

COO earnings per share forecast

What is COO's earnings per share in the next 3 years based on estimates from 8 analysts?

Avg 1 year Forecast
$4.06+95.13%
Avg 2 year Forecast
$4.46+114.3%
Avg 3 year Forecast
$4.95+137.79%
COO's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

COO revenue forecast

What is COO's revenue in the next 3 years based on estimates from 7 analysts?

Avg 1 year Forecast
$4.1B+3.26%
Avg 2 year Forecast
$4.4B+9.88%
Avg 3 year Forecast
$4.6B+16.14%
COO's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

COO earnings growth forecast

How is COO forecast to perform vs Medical Instruments & Supplies companies and vs the US market?

Company
46.84%
Industry
19.23%
Market
19.75%
COO's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
COO's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
COO's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

COO revenue growth forecast

How is COO forecast to perform vs Medical Instruments & Supplies companies and vs the US market?

Company
4.77%
Industry
7.65%
Market
11.67%
COO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
COO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

COO vs Medical Stocks

TickerPricePrice TargetUp/downsideConsensus
COO$75.22$96.25+27.96%Strong Buy
HOLX$68.26$73.13+7.13%Buy
BAX$24.54$31.50+28.36%Hold
WST$247.85$305.00+23.06%Buy
ATR$141.43$162.50+14.90%Strong Buy
View Top Medical Stocks

Cooper Companies Stock Forecast FAQ

Is Cooper Companies Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 8 Wall Street analysts covering (NASDAQ: COO) stock is to Strong Buy COO stock.

Out of 8 analysts, 4 (50%) are recommending COO as a Strong Buy, 3 (37.5%) are recommending COO as a Buy, 1 (12.5%) are recommending COO as a Hold, 0 (0%) are recommending COO as a Sell, and 0 (0%) are recommending COO as a Strong Sell.

If you're new to stock investing, here's how to buy Cooper Companies stock.

What is COO's earnings growth forecast for 2025-2027?

(NASDAQ: COO) Cooper Companies's forecast annual earnings growth rate of 46.84% is forecast to beat the US Medical Instruments & Supplies industry's average forecast earnings growth rate of 19.23%, and it is also forecast to beat the US market's average forecast earnings growth rate of 19.75%.

Cooper Companies's earnings in 2025 is $414,200,000.On average, 8 Wall Street analysts forecast COO's earnings for 2025 to be $809,781,351, with the lowest COO earnings forecast at $794,059,766, and the highest COO earnings forecast at $818,001,266. On average, 8 Wall Street analysts forecast COO's earnings for 2026 to be $889,326,987, with the lowest COO earnings forecast at $865,884,267, and the highest COO earnings forecast at $909,777,018.

In 2027, COO is forecast to generate $986,788,845 in earnings, with the lowest earnings forecast at $957,660,019 and the highest earnings forecast at $1,021,504,020.

What is COO's revenue growth forecast for 2025-2027?

(NASDAQ: COO) Cooper Companies's forecast annual revenue growth rate of 4.77% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 7.65%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.67%.

Cooper Companies's revenue in 2025 is $3,988,200,000.On average, 7 Wall Street analysts forecast COO's revenue for 2025 to be $821,637,980,323, with the lowest COO revenue forecast at $820,964,027,084, and the highest COO revenue forecast at $822,889,322,748. On average, 7 Wall Street analysts forecast COO's revenue for 2026 to be $874,336,814,104, with the lowest COO revenue forecast at $868,332,285,784, and the highest COO revenue forecast at $879,989,801,393.

In 2027, COO is forecast to generate $924,109,397,990 in revenue, with the lowest revenue forecast at $916,241,223,370 and the highest revenue forecast at $934,596,373,738.

What is COO's forecast return on assets (ROA) for 2025-2027?

(NASDAQ: COO) forecast ROA is 7.95%, which is lower than the forecast US Medical Instruments & Supplies industry average of 12.55%.

What is COO's Price Target?

According to 8 Wall Street analysts that have issued a 1 year COO price target, the average COO price target is $96.25, with the highest COO stock price forecast at $110.00 and the lowest COO stock price forecast at $76.00.

On average, Wall Street analysts predict that Cooper Companies's share price could reach $96.25 by Jul 16, 2026. The average Cooper Companies stock price prediction forecasts a potential upside of 27.96% from the current COO share price of $75.22.

What is COO's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: COO) Cooper Companies's current Earnings Per Share (EPS) is $2.08. On average, analysts forecast that COO's EPS will be $4.06 for 2025, with the lowest EPS forecast at $3.98, and the highest EPS forecast at $4.10. On average, analysts forecast that COO's EPS will be $4.46 for 2026, with the lowest EPS forecast at $4.34, and the highest EPS forecast at $4.56. In 2027, COO's EPS is forecast to hit $4.95 (min: $4.80, max: $5.12).

What is COO's forecast return on equity (ROE) for 2025-2027?

(NASDAQ: COO) forecast ROE is 11.91%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.